Cargando…
Drug repurposing for COVID-19 based on an integrative meta-analysis of SARS-CoV-2 induced gene signature in human airway epithelium
Drug repurposing has the potential to bring existing de-risked drugs for effective intervention in an ongoing pandemic—COVID-19 that has infected over 131 million, with 2.8 million people succumbing to the illness globally (as of April 04, 2021). We have used a novel `gene signature’-based drug repo...
Autores principales: | Gupta, Rajaneesh K., Nwachuku, Enyinna L., Zusman, Benjamin E., Jha, Ruchira M., Puccio, Ava M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8478222/ https://www.ncbi.nlm.nih.gov/pubmed/34582497 http://dx.doi.org/10.1371/journal.pone.0257784 |
Ejemplares similares
-
B-Cell Lymphoma 2 (Bcl-2) and Regulation of Apoptosis after Traumatic Brain Injury: A Clinical Perspective
por: Deng, Hansen, et al.
Publicado: (2020) -
Hydrocephalus and Cerebrospinal Fluid Analysis Following Severe Traumatic Brain Injury: Evaluation of a Prospective Cohort
por: Deng, Hansen, et al.
Publicado: (2021) -
Pilot Biomarker Analysis and Decision Tree Algorithm Modeling of Patients with Chronic Subdural Hematomas
por: Puccio, David J., et al.
Publicado: (2023) -
Power Drill Craniostomy for Bedside Intracranial Access in Traumatic Brain Injury Patients
por: Deng, Hansen, et al.
Publicado: (2023) -
Genetic Variants Associated With Intraparenchymal Hemorrhage Progression After Traumatic Brain Injury
por: Jha, Ruchira M., et al.
Publicado: (2021)